Level Chart

Basic Info

Pfizer Inc (PFE) - Inflammation & Immunology Revenue is at a current level of 0.000, unchanged from 0.000 last quarter and down from 821.00M one year ago. This is a change of N/A from last quarter and -100.0% from one year ago.

Pfizer Inc Inflammation & Immunology Revenue represents the revenue generated by the company from the sale of pharmaceutical products and therapies within the Inflammation & Immunology segment.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 0.00
Latest Period Jul 2023
Last Updated Oct 5 2023, 11:15 EDT
Average Growth Rate -45.31%
Value from Last Quarter 0.00
Change from Last Quarter N/A
Value from 1 Year Ago 821.00M
Change from 1 Year Ago -100.0%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
July 02, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
October 02, 2022 0.00
July 03, 2022 850.00M
April 03, 2022 821.00M
December 31, 2021 1.231B
October 03, 2021 1.094B
Date Value
July 04, 2021 1.041B
April 04, 2021 1.065B
December 31, 2020 1.267B
September 27, 2020 1.173B
June 28, 2020 1.149B
March 29, 2020 978.00M
December 31, 2019 1.251B

Basic Info

Pfizer Inc (PFE) - Inflammation & Immunology Revenue is at a current level of 0.000, unchanged from 0.000 last quarter and down from 821.00M one year ago. This is a change of N/A from last quarter and -100.0% from one year ago.

Pfizer Inc Inflammation & Immunology Revenue represents the revenue generated by the company from the sale of pharmaceutical products and therapies within the Inflammation & Immunology segment.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 0.00
Latest Period Jul 2023
Last Updated Oct 5 2023, 11:15 EDT
Average Growth Rate -45.31%
Value from Last Quarter 0.00
Change from Last Quarter N/A
Value from 1 Year Ago 821.00M
Change from 1 Year Ago -100.0%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
PFE Pfizer Inc 0.30%